Related Experiment Videos

Regression of cutaneous neoplasms following delayed-type hypersensitivity challenge reactions to microbial antigens

Journal of Medicine
|January 1, 1975
PubMed

Insights

Inducing delayed-type hypersensitivity reactions at tumor sites led to cancer regression. Large mononuclear cells in these reactions may be key to this anti-tumor effect.

Area of Science:

  • Immunology
  • Dermatology
  • Oncology

Background:

  • Delayed-type hypersensitivity (DTH) reactions are a key component of cell-mediated immunity.
  • Tumor immunology explores the complex interactions between the immune system and cancer.
  • Investigating immune responses at the tumor site can reveal mechanisms of tumor rejection.

Observation:

  • Challenging skin neoplasms with microbial antigens induced DTH reactions.
  • These DTH reactions were followed by tumor regression in various skin cancers.
  • Similar regressions were observed when using lymphokine preparations.

Findings:

  • DTH reactions at tumor sites correlated with regression of mycosis fungoides, reticulum cell sarcoma, basal cell carcinoma, and breast adenocarcinoma.
  • Lymphokine-induced DTH reactions also showed efficacy against mycosis fungoides and basal cell carcinoma.
  • Large mononuclear cells within the DTH infiltrate were identified as potential mediators of tumor regression.

Implications:

  • The findings suggest a potential therapeutic strategy utilizing DTH reactions for cancer treatment.
  • Large mononuclear cells may play a crucial role in immune surveillance against neoplastic cells.
  • This research provides insights into the primitive immune surveillance mechanisms against cancer.

Related Concept Videos